TipRanks
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market
GLENMARK
Glenmark Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:GLENMARK full AI Analyst Report?

Glenmark Pharmaceuticals Limited (GLENMARK) Ratios

5 Followers

Glenmark Pharmaceuticals Limited Ratios

IN:GLENMARK's free cash flow for Q4 2026 was ₹0.41. For the 2026 fiscal year, IN:GLENMARK's free cash flow was decreased by ₹ and operating cash flow was ₹0.11. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.77 1.77 1.56 1.28 2.10
Quick Ratio
 1.23 1.23 1.01 0.84 1.64
Cash Ratio
 0.18 0.18 0.29 0.28 0.23
Solvency Ratio
 0.26 0.21 0.18 -0.17 0.06
Operating Cash Flow Ratio
 0.44 0.52 -0.14 -0.05 0.12
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.49 -0.27 1.26
Net Current Asset Value
₹ 19.04B₹ 19.04B₹ 20.95B₹ 9.17B₹ 11.93B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.15 0.09 0.24
Debt-to-Equity Ratio
 0.06 0.06 0.28 0.16 0.49
Debt-to-Capital Ratio
 0.05 0.05 0.22 0.14 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.05 0.00 0.29
Financial Leverage Ratio
 1.89 1.89 1.81 1.83 2.04
Debt Service Coverage Ratio
 12.81 10.27 0.96 -0.03 1.30
Interest Coverage Ratio
 17.55 19.16 20.20 6.58 8.05
Debt to Market Cap
 0.00 0.00 0.05 0.04 0.33
Interest Debt Per Share
 28.28 28.43 94.96 61.91 175.67
Net Debt to EBITDA
 -0.17 -0.21 0.35 -0.23 2.41
Profitability Margins
Gross Profit Margin
47.32%47.60%66.14%63.79%62.16%
EBIT Margin
15.43%12.92%14.27%11.43%9.76%
EBITDA Margin
18.91%16.29%16.22%14.47%12.26%
Operating Profit Margin
20.24%23.55%31.31%26.84%24.12%
Pretax Profit Margin
14.28%11.69%10.47%0.29%2.06%
Net Profit Margin
10.14%8.02%7.84%-11.88%2.55%
Continuous Operations Profit Margin
10.14%8.02%7.84%-14.48%-0.77%
Net Income Per EBT
70.99%68.62%74.83%-4114.72%123.93%
EBT Per EBIT
70.55%49.63%33.44%1.08%8.53%
Return on Assets (ROA)
9.03%6.84%6.52%-10.46%1.53%
Return on Equity (ROE)
18.67%12.96%11.83%-19.13%3.14%
Return on Capital Employed (ROCE)
26.53%29.55%41.50%39.74%19.71%
Return on Invested Capital (ROIC)
18.68%20.12%26.41%-1770.16%-7.07%
Return on Tangible Assets
10.33%7.83%7.18%-11.53%1.75%
Earnings Yield
2.68%2.26%2.46%-5.42%2.27%
Efficiency Ratios
Receivables Turnover
 3.57 3.42 3.20 6.80 3.59
Payables Turnover
 2.50 2.38 1.75 1.81 2.20
Inventory Turnover
 2.72 2.59 1.38 1.82 1.86
Fixed Asset Turnover
 4.11 3.93 3.46 3.57 2.76
Asset Turnover
 0.89 0.85 0.83 0.88 0.60
Working Capital Turnover Ratio
 7.21 4.12 5.41 3.50 2.53
Cash Conversion Cycle
 89.91 93.83 170.80 51.82 132.55
Days of Sales Outstanding
 102.14 106.68 114.20 53.64 101.66
Days of Inventory Outstanding
 134.01 140.72 264.67 200.32 196.42
Days of Payables Outstanding
 146.24 153.56 208.07 202.15 165.54
Operating Cycle
 236.15 247.40 378.87 253.97 298.08
Cash Flow Ratios
Operating Cash Flow Per Share
 100.48 116.91 -29.33 -9.41 22.16
Free Cash Flow Per Share
 82.75 68.80 -55.89 -41.25 0.62
CapEx Per Share
 17.73 48.11 26.56 31.84 21.54
Free Cash Flow to Operating Cash Flow
 0.82 0.59 1.91 4.38 0.03
Dividend Paid and CapEx Coverage Ratio
 5.67 2.20 -1.01 -0.26 0.84
Capital Expenditure Coverage Ratio
 5.67 2.43 -1.10 -0.30 1.03
Operating Cash Flow Coverage Ratio
 4.78 5.56 -0.33 -0.22 0.14
Operating Cash Flow to Sales Ratio
 0.16 0.19 -0.06 -0.02 0.05
Free Cash Flow Yield
3.48%3.23%-3.70%-4.20%0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.36 44.17 40.67 -18.46 44.11
Price-to-Sales (P/S) Ratio
 3.79 3.54 3.19 2.19 1.12
Price-to-Book (P/B) Ratio
 6.39 5.72 4.81 3.53 1.38
Price-to-Free Cash Flow (P/FCF) Ratio
 28.76 30.98 -27.00 -23.82 743.79
Price-to-Operating Cash Flow Ratio
 23.69 18.23 -51.46 -104.44 20.97
Price-to-Earnings Growth (PEG) Ratio
 0.27 1.47 -0.26 -0.02 -0.37
Price-to-Fair Value
 6.39 5.72 4.81 3.53 1.38
Enterprise Value Multiple
 19.85 21.53 20.00 14.92 11.59
Enterprise Value
 665.81B 595.72B 433.55B 272.95B 165.61B
EV to EBITDA
 19.85 21.53 20.00 14.92 11.59
EV to Sales
 3.75 3.51 3.24 2.16 1.42
EV to Free Cash Flow
 28.51 30.68 -27.49 -23.45 939.42
EV to Operating Cash Flow
 23.48 18.06 -52.39 -102.83 26.48
Tangible Book Value Per Share
 283.68 283.69 261.84 230.82 263.07
Shareholders’ Equity Per Share
 372.51 372.52 313.60 278.13 335.75
Tax and Other Ratios
Effective Tax Rate
 0.29 0.31 0.25 51.17 1.37
Revenue Per Share
 628.51 601.81 473.56 448.15 413.07
Net Income Per Share
 63.71 48.26 37.11 -53.22 10.53
Tax Burden
 0.71 0.69 0.75 -41.15 1.24
Interest Burden
 0.93 0.90 0.73 0.03 0.21
Research & Development to Revenue
 0.00 0.00 0.07 0.10 0.11
SG&A to Revenue
 0.16 0.24 0.28 0.23 0.23
Stock-Based Compensation to Revenue
 <0.01 0.00 >-0.01 <0.01 <0.01
Income Quality
 2.01 2.42 -0.59 0.18 0.72
Currency in INR